Epstein Barr Virus Methods and Protocols /

Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Minarovits, Janos. (Editor), Niller, Hans Helmut. (Editor)
Format: eBook
Language:English
Published: New York, NY : Springer New York : Imprint: Humana, 2017.
Edition:1st ed. 2017.
Series:Methods in Molecular Biology, 1532
Subjects:
Online Access:https://doi.org/10.1007/978-1-4939-6655-4
Table of Contents:
  • Current Trends and Alternative Scenarios in EBV Research
  • Epstein-Barr Virus: Clinical Diagnostics
  • Establishment of EBV-Infected Lymphoblastoid Cell Lines
  • Generation and Infection of Organotypic Cultures with Epstein-Barr Virus
  • Affinity Purification-Mass Spectroscopy Methods for Identifying Epstein-Barr Virus-Host Interactions
  • The Use of 3D Telomere FISH for the Characterization of the Nuclear Architecture in EBV-Positive Hodgkin's Lymphoma
  • Analysis of EBV Transcription Using High-Throughput RNA Sequencing
  • Analysis of Viral Promoter Usage in EBV-Infected Cell Lines: A Comparison of qPCR following Conventional RNA Isolation and Nuclear Run-On Assay
  • Analysis of Viral and Cellular MicroRNAs in EBV Infected Cells
  • Isolation and Characterization of Exosomes Released by EBV Immortalized Cells
  • Functional Analysis of Exosomes Derived from EBV-Infected Cells
  • Terminal Repeat Analysis of EBV Genomes
  • Characterization of EBV Promoters and Coding Regions by Sequencing PCR-Amplified DNA Fragments
  • The Use of Chromatin Precipitation Coupled to DNA Sequencing (ChIP-Seq) for the Analysis of Zta Binding to the Human and EBV Genome
  • Analysis of Viral Epigenotypes Using Bisulfite Sequencing: A Detailed Protocol for the Crucial Bisulfite Modification and PCR Amplification Steps
  • Analysis of Viral Epigenotypes using Chromatin Immunoprecipitation
  • Mice with Reconstituted Human Immune System Components as a Tool to Study Immune Cell Interactions in EBV Infection
  • Generation and Analysis of Humanized Mouse Model of EBV Infection
  • EBV-Directed T Cell Therapeutics for EBV-Associated Lymphomas.